Wells David R. 4
4 · ENDRA Life Sciences Inc. · Filed Jan 28, 2020
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Award
Stock Options
2020-01-25+20,000→ 20,000 totalExercise: $1.71Exp: 2030-01-25→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in three equal annual installments beginning January 25, 2021.